Back to Search
MATTHEW PESEK, DO
DO
Diagnostic Radiology Physician
NPI: 1538281829IndividualAccepts Medicare
Education
KANSAS CITY UNIVERSITY OF PHYSICIANS AND SURGEONS
Class of 2002
Research & Publications (16)
Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.
PMID 19596959·Anticancer Res·2009
8-other
Differentiated expression of the lactate dehydrogenase subunit M in pleural fluids of neoplastic aetiology.
PMID 18821170·Scand J Clin Lab Invest·2009
8-other
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
PMID 19596921·Anticancer Res·2009
8-other
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
PMID 18779612·J Clin Oncol·2008
3-trial
Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
PMID 19112411·Neuro Endocrinol Lett·2008
4-observational
Duration of untreated psychosis and it's effect on the functional outcome in schizophrenia - preliminary results.
PMID 18587288·Psychiatr Danub·2008
8-other
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
PMID 17878479·J Clin Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1400 US HIGHWAY 61
FESTUS, MO 63028 - Phone
- (636) 933-1059
Quick Facts
- NPI
- 1538281829
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 24
- Publications
- 16
Are you this provider?
Claim Your Profile